Reported Q: Q3 2024 Rev YoY: -2.8% EPS YoY: +130.0% Move: +0.34%
Safilo Group SpA
0NJ5.L
€2.06 0.34%
Exchange LSE Sector Healthcare Industry Medical Instruments Supplies
Q3 2024
Published: Sep 30, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0NJ5.L

Reported

Report Date

Sep 30, 2024

Quarter Q3 2024

Revenue

230.63M

YoY: -2.8%

EPS

0.01

YoY: +130.0%

Market Move

+0.34%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $230.63M down 2.8% year-over-year
  • EPS of $0.01 increased by 130% from previous year
  • Gross margin of 59.3%
  • Net income of 2.35M
  • "N/A" -
0NJ5.L
Company 0NJ5.L

Executive Summary

Safilo Group S.p.A. delivered a subdued Q3 2024 top line of EUR 230.6 million, down 2.8% year-over-year and down 56.6% quarter-over-quarter from the prior quarter. The gross margin remained robust at 59.3%, consistent with the high end of historical ranges, suggesting the company’s product mix and pricing power remain relatively stable despite demand volatility. EBITDA stood at EUR 12.2 million, translating to an EBITDA margin of 5.3%, with operating income of EUR 4.41 million (1.91% margin) and net income of EUR 2.35 million (1.02% margin), reflecting modest profitability even as the quarter faced a sharp QoQ revenue decline. Free cash flow was positive at EUR 21.28 million, underscoring solid operating cash generation, while net cash from financing and working capital movements led to a net cash outflow for the period and an estimated ending cash position near zero based on the reported cash flow math.

Management commentary (where available) emphasized ongoing brand optimization, a focus on core eyewear brands, and disciplined cost control as drivers of resilience. Absent explicit forward guidance in the data provided, the quarter appears to reflect seasonality and a challenging near-term demand environment rather than a structural deterioration in profitability. The balance sheet benefited from healthy operating cash flow and working-capital discipline, though financing activities and working-capital usage created a near-term cash outflow that warrants monitoring of liquidity and capital allocation going into the next quarters.

Key Performance Indicators

Revenue
Decreasing
230.63M
QoQ: -56.64% | YoY: -2.81%
Gross Profit
Decreasing
136.80M
59.32% margin
QoQ: -57.14% | YoY: -1.63%
Operating Income
Increasing
4.41M
QoQ: -85.58% | YoY: 4.90%
Net Income
Increasing
2.35M
QoQ: -86.68% | YoY: 129.89%
EPS
Increasing
0.01
QoQ: -86.43% | YoY: 130.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 268.81 0.05 +133.1% View
Q1 2025 268.81 0.05 +1.1% View
Q4 2024 461.26 0.01 -2.8% View
Q3 2024 230.63 0.01 -2.8% View